Cheminformatic Tools and Databases for Pharmacology

session 95233 - Total of 2 hits - Display   hits per page:

Add another drug(s) by one keyword:
Exemple: “nib“ and click on the Search button (do not press Enter on the keyboard)

1 INNClassRoute (list)PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)Primary Target and PDB code of Protein-Drug complexTargets from DrugCentral Links
RAMIPRIL (has an active metabolite)

RAMIPRIL


ATC C09AA05
ATC C09BB07
ATC C09BA05
ATC C09BB05
ATC C09BX03
ATC C10BX06
ATC C10BX04
ATC C10BX17

CARDIOVASCULAR
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS
ANTIHYPERTENSIVE AGENTS

ORAL

Tmax 1 HOUR

F 28 PERCENT

PPB 73 PERCENT

ANGIOTENSIN-CONVERTING ENZYME

ANGIOTENSIN-CONVERTING ENZYME INHIBITOR CHEMBL1808 ANGIOTENSIN-CONVERTING ENZYME P12821 ANGIOTENSIN-CONVERTING ENZYME HOMO SAPIENS ENZYME PROTEASE METALLO MAE M2ANSM (in French)

Dailymed
Drugs.com

SIDER side effects

Chemical Probes Portal

ChEMBL
BindingDB
DrugBank

2 INNClassRoute (list)PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)Primary Target and PDB code of Protein-Drug complexTargets from DrugCentral Links
RAMIPRILAT (is an active metabolite)

RAMIPRILAT


ATC C09AA05
ATC C09BB07
ATC C09BA05
ATC C09BB05
ATC C10BX06
ATC C09BX03
ATC C10BX04
ATC C10BX17

CARDIOVASCULAR
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS
ANTIHYPERTENSIVE AGENTS

-

Tmax 3 HOUR

F 44 PERCENT

PPB 56 PERCENT

HT 15 HOUR

ANGIOTENSIN-CONVERTING ENZYME

ANGIOTENSIN-CONVERTING ENZYME INHIBITOR CHEMBL1808 ANGIOTENSIN-CONVERTING ENZYME P12821 ANGIOTENSIN-CONVERTING ENZYME HOMO SAPIENS ENZYME PROTEASE METALLO MAE M2ANSM (in French)

Dailymed
Drugs.com

SIDER side effects

Chemical Probes Portal

ChEMBL
BindingDB
DrugBank



Copyright © 2019 Université Côte d'Azur CNRS - All rights reserved
  | Contact |